论文部分内容阅读
据报道,2型糖尿病在美国年轻的少数民族妇女中的发病率有所增加,因此了解这一群体应用复合口服避孕药(OCs)与葡萄糖不耐受之间的关联性就显得尤为重要。美国约有1000多万名妇女口服复合雌-孕激素避孕药;且大多数研究已证实OCs与血糖和胰岛素水平升高相关联。
It has been reported that the incidence of type 2 diabetes is increasing among younger ethnic minority women in the United States, and it is therefore particularly important to understand the association between composite oral contraceptives (OCs) and glucose intolerance in this population. About 10 million women in the United States orally take a combination of estrogen-progestin contraceptives; and most studies have shown that OCs are associated with elevated blood glucose and insulin levels.